| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Men |
| Source | Futurism |
| URL | futurism.com/health-medicine/andrew-huberman-trt (opens in a new tab) |
Specific Claim Evaluated
A podcast host described himself as being on low-dose testosterone replacement at about 125 mg a week.
Primary Research Supporting or Contradicting the Claim
The Endocrine Society guideline gives a usual replacement regimen of testosterone enanthate or cypionate 75 to 100 mg weekly or 150 to 200 mg every 2 weeks (Bhasin et al., 2018).
Corrected Evidence-Based Interpretation
A weekly dose of 125 mg is at or above a standard full replacement dose, not a low dose, and requires the same monitoring of hematocrit and fertility as other replacement regimens.
Rationale for Grade
The article reports the statement accurately and focuses on disclosure and conflicts of interest. It repeats the description of the dose as low without noting that the stated amount is a full replacement dose, an omission that could mislead readers about the regimen.
References
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs"